Quadrant Capital Group LLC Pacific Biosciences Of California, Inc. Transaction History
Quadrant Capital Group LLC
- $3 Billion
- Q3 2025
A detailed history of Quadrant Capital Group LLC transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Quadrant Capital Group LLC holds 1,365 shares of PACB stock, worth $2,197. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,365
Previous 12,016
88.64%
Holding current value
$2,197
Previous $14,000
92.86%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding PACB
# of Institutions
244Shares Held
190MCall Options Held
1.27MPut Options Held
601K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl30.9MShares$49.8 Million0.28% of portfolio
-
Black Rock Inc. New York, NY23.6MShares$38 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M020.5MShares$32.9 Million0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.4MShares$26.4 Million0.0% of portfolio
-
Edmond De Rothschild Holding S.A. Chambesy, V810.7MShares$17.2 Million0.21% of portfolio
About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- Ticker PACB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 224,840,992
- Market Cap $362M
- Description
- Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...